BOSTON, MA, Granata Bio, a biopharma company, announced the close of a $14M Series A funding round led by GV.
Granata Bio, Inc. a biopharma company focused on invigorating the $3.6B global infertility medication market, announced the close of a $14M Series A funding round led by GV (Google Ventures). Participants in the funding round include CooperSurgical, Gedeon Richter, Alumni Ventures, Amboy Street Ventures, Vibe Bio and others.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
